{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:21:02Z","timestamp":1790104862839,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T00:00:00Z","timestamp":1235347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2334-9-21","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T07:23:44Z","timestamp":1235460224000},"source":"Crossref","is-referenced-by-count":8,"title":["Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis"],"prefix":"10.1186","volume":"9","author":[{"given":"Timothy","family":"Lahey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mecky","family":"Matee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Mtei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisali","family":"Pallangyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Fordham","family":"von Reyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,23]]},"reference":[{"issue":"9514","key":"786_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","volume":"367","author":"C Dye","year":"2006","unstructured":"Dye C: Global epidemiology of tuberculosis. Lancet. 2006, 367 (9514): 938-940. 10.1016\/S0140-6736(06)68384-0.","journal-title":"Lancet"},{"issue":"5","key":"786_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/01.aids.0000216376.07185.cc","volume":"20","author":"DW Dowdy","year":"2006","unstructured":"Dowdy DW, Chaisson RE, Moulton LH, Dorman SE: The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. Aids. 2006, 20 (5): 751-762. 10.1097\/01.aids.0000216376.07185.cc.","journal-title":"Aids"},{"key":"786_CR3","unstructured":"The global plan to stop TB, 2006-2015\/Stop TB Partnership. [ http:\/\/www.stoptb.org\/globalplan\/assets\/documents\/GlobalPlanFinal.pdf ]"},{"issue":"5","key":"786_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"D Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146 (5): 340-354.","journal-title":"Ann Intern Med"},{"issue":"1","key":"786_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","volume":"170","author":"T Mori","year":"2004","unstructured":"Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, et al: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004, 170 (1): 59-64. 10.1164\/rccm.200402-179OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"786_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1128\/JCM.40.2.704-706.2002","volume":"40","author":"TM Doherty","year":"2002","unstructured":"Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, Ravn P, Andersen P: Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002, 40 (2): 704-706. 10.1128\/JCM.40.2.704-706.2002.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"786_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","volume":"177","author":"R Diel","year":"2008","unstructured":"Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A: Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008, 177 (10): 1164-1170. 10.1164\/rccm.200711-1613OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"786_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1365-2249.1997.509-ce1407.x","volume":"110","author":"H Silveira","year":"1997","unstructured":"Silveira H, Ordway D, Dockrell H, Jackson M, Ventura F: Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol. 1997, 110 (1): 26-34. 10.1111\/j.1365-2249.1997.509-ce1407.x.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"786_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1086\/322670","volume":"33","author":"TR Sterling","year":"2001","unstructured":"Sterling TR, Dorman SE, Chaisson RE, Ding L, Hackman J, Moore K, Holland SM: Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses. Clin Infect Dis. 2001, 33 (7): 976-982. 10.1086\/322670.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"786_CR10","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1086\/518234","volume":"44","author":"MX Rangaka","year":"2007","unstructured":"Rangaka MX, Diwakar L, Seldon R, van Cutsem G, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, et al: Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis. 2007, 44 (12): 1639-1646. 10.1086\/518234.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"786_CR11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.158.1.492","volume":"158","author":"JF McDyer","year":"1997","unstructured":"McDyer JF, Hackley MN, Walsh TE, Cook JL, Seder RA: Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses. J Immunol. 1997, 158 (1): 492-500.","journal-title":"J Immunol"},{"issue":"6","key":"786_CR12","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1172\/JCI117611","volume":"94","author":"M Zhang","year":"1994","unstructured":"Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF: T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest. 1994, 94 (6): 2435-2442. 10.1172\/JCI117611.","journal-title":"J Clin Invest"},{"issue":"9\u201310","key":"786_CR13","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.micinf.2005.03.020","volume":"7","author":"S Winkler","year":"2005","unstructured":"Winkler S, Necek M, Winkler H, Adegnika AA, Perkmann T, Ramharter M, Kremsner PG: Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa. Microbes Infect. 2005, 7 (9\u201310): 1161-1169. 10.1016\/j.micinf.2005.03.020.","journal-title":"Microbes Infect"},{"issue":"2","key":"786_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijid.2004.05.009","volume":"9","author":"MD Oh","year":"2005","unstructured":"Oh MD, Kang CI, Kim US, Kim NJ, Lee B, Kim HB, Choe KW: Cytokine responses induced by Mycobacterium tuberculosis in patients with HIV-1 infection and tuberculosis. Int J Infect Dis. 2005, 9 (2): 110-116. 10.1016\/j.ijid.2004.05.009.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"786_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00126334-200001010-00010","volume":"23","author":"R Wood","year":"2000","unstructured":"Wood R, Maartens G, Lombard CJ: Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr. 2000, 23 (1): 75-80.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"786_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1378\/chest.122.2.597","volume":"122","author":"NW Schluger","year":"2002","unstructured":"Schluger NW, Perez D, Liu YM: Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest. 2002, 122 (2): 597-602. 10.1378\/chest.122.2.597.","journal-title":"Chest"},{"issue":"6","key":"786_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/01.aids.0000218545.31716.a4","volume":"20","author":"R Sutherland","year":"2006","unstructured":"Sutherland R, Yang H, Scriba TJ, Ondondo B, Robinson N, Conlon C, Suttill A, McShane H, Fidler S, McMichael A, et al: Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. Aids. 2006, 20 (6): 821-829. 10.1097\/01.aids.0000218545.31716.a4.","journal-title":"Aids"},{"issue":"10","key":"786_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1086\/429825","volume":"40","author":"L Mtei","year":"2005","unstructured":"Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, Cole BF, Vuola JM, Tvaroha S, Kreiswirth B, et al: High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis. 2005, 40 (10): 1500-1507. 10.1086\/429825.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"786_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/509896","volume":"195","author":"M Matee","year":"2007","unstructured":"Matee M, Lahey T, Vuola JM, Mtei L, Cole BF, Bakari M, Arbeit RD, Horsburgh CR, Pallangyo K, von Reyn CF: Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Guerin during childhood and entering a tuberculosis booster vaccine trial. J Infect Dis. 2007, 195 (1): 118-123. 10.1086\/509896.","journal-title":"J Infect Dis"},{"issue":"16","key":"786_CR20","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1097\/00002030-200311070-00010","volume":"17","author":"JM Vuola","year":"2003","unstructured":"Vuola JM, Ristola MA, Cole B, Jarviluoma A, Tvaroha S, Ronkko T, Rautio O, Arbeit RD, Reyn CF: Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial. Aids. 2003, 17 (16): 2351-2355. 10.1097\/00002030-200311070-00010.","journal-title":"Aids"},{"issue":"8","key":"786_CR21","first-page":"883","volume":"10","author":"TJ Joos","year":"2006","unstructured":"Joos TJ, Miller WC, Murdoch DM: Tuberculin reactivity in bacille Calmette-Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis. 2006, 10 (8): 883-891.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"786_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7326\/0003-4819-119-3-199308010-00002","volume":"119","author":"N Markowitz","year":"1993","unstructured":"Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Osmond D, Wallace JM, Rosen MJ, et al: Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med. 1993, 119 (3): 185-193.","journal-title":"Ann Intern Med"},{"issue":"3","key":"786_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/ajrccm\/145.3.621","volume":"145","author":"R Menzies","year":"1992","unstructured":"Menzies R, Vissandjee B: Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992, 145 (3): 621-625.","journal-title":"Am Rev Respir Dis"},{"issue":"17","key":"786_CR24","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/00002030-200211220-00008","volume":"16","author":"AL Chapman","year":"2002","unstructured":"Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, Reece WH, Mwinga A, Godfrey-Faussett P, Lalvani A: Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. Aids. 2002, 16 (17): 2285-2293. 10.1097\/00002030-200211220-00008.","journal-title":"Aids"},{"issue":"6","key":"786_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1473-3099(07)70086-5","volume":"7","author":"M Pai","year":"2007","unstructured":"Pai M, Dheda K, Cunningham J, Scano F, O'Brien R: T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis. 2007, 7 (6): 428-438. 10.1016\/S1473-3099(07)70086-5.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"786_CR26","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1086\/340397","volume":"34","author":"B Bellete","year":"2002","unstructured":"Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW, Bishai WR: Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis. 2002, 34 (11): 1449-1456. 10.1086\/340397.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"786_CR27","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1128\/JCM.02411-05","volume":"44","author":"SJ Tsiouris","year":"2006","unstructured":"Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W: Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006, 44 (8): 2844-2850. 10.1128\/JCM.02411-05.","journal-title":"J Clin Microbiol"},{"issue":"22","key":"786_CR28","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","author":"YA Kang","year":"2005","unstructured":"Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. Jama. 2005, 293 (22): 2756-2761. 10.1001\/jama.293.22.2756.","journal-title":"Jama"},{"key":"786_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2334-7-99","volume":"7","author":"SD Lawn","year":"2007","unstructured":"Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobongwana M, Dockrell HM, Wilkinson RJ, Wood R: Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis. 2007, 7: 99-10.1186\/1471-2334-7-99.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"786_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.2007.03477.x","volume":"150","author":"SA Clark","year":"2007","unstructured":"Clark SA, Martin SL, Pozniak A, Steel A, Ward B, Dunning J, Henderson DC, Nelson M, Gazzard B, Kelleher P: Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol. 2007, 150 (2): 238-244.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"786_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1365-2249.2001.01401.x","volume":"123","author":"Z Toossi","year":"2001","unstructured":"Toossi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, Hom DL, Aung H, Mugyenyi P, Ellner JJ, Whalen CW: Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol. 2001, 123 (2): 233-238. 10.1046\/j.1365-2249.2001.01401.x.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"786_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1086\/381763","volume":"38","author":"A Lalvani","year":"2004","unstructured":"Lalvani A: Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment?. Clin Infect Dis. 2004, 38 (5): 757-759. 10.1086\/381763.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"786_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1086\/381754","volume":"38","author":"S Carrara","year":"2004","unstructured":"Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D: Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004, 38 (5): 754-756. 10.1086\/381754.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"786_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/00002030-199310000-00007","volume":"7","author":"A Guelar","year":"1993","unstructured":"Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miro JM, Mallolas J, Zamora L, Gonzalez J, et al: A prospective study of the risk of tuberculosis among HIV-infected patients. Aids. 1993, 7 (10): 1345-1349. 10.1097\/00002030-199310000-00007.","journal-title":"Aids"},{"issue":"6","key":"786_CR35","first-page":"576","volume":"2","author":"RL Colebunders","year":"1989","unstructured":"Colebunders RL, Lebughe I, Nzila N, Kalunga D, Francis H, Ryder R, Piot P: Cutaneous delayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire. J Acquir Immune Defic Syndr. 1989, 2 (6): 576-578.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-9-21\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T04:07:22Z","timestamp":1684901242000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-9-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-9-21","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,23]]},"article-number":"21"}}